Home>Topics>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. Commentary
  3. Video Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
  1. Positive Prognosis For Biotech ETFs

    Headlines

    Mon, 13 May 2013

    By Tom Lydon : The biotechnology sector has positive long-term implications and the indecision that loomed over the industry has subsided, according to S&P Capital. Exchange traded funds that track this sector are a sound choice for risk mitigation while gaining exposure to growth going forward. ...

  2. Gilead's Hepatitis C Drug Sofosbuvir Offers Upside

    Headlines

    Thu, 9 May 2013

    best performing industries this year has been biotechnology. The S&P biotechnology ETF ( XBI ) and the Nasdaq Biotech ETF ( IBB ) have returned 27% and 18% year-to-date, respectively. Those returns are nicely ahead of the 14% return clocked by

  3. Islamic Bank of Britain narrows loss, gets capital from QIIB

    Headlines

    Tue, 30 Apr 2013

    SYDNEY, April 30 (Reuters) - Islamic Bank of Britain ( IBB ) narrowed its losses in 2012, Britain's only sharia-compliant retail lender said, a week after it raised 10 million pounds ($15.5 million) from majority shareholder Qatar International Islamic Bank.

  4. Beat Obamacare With These Biotech ETFs

    Headlines

    Mon, 22 Apr 2013

    largest ETF in the biotech sector is the iShares Biotech ETF ( IBB ). The fund currently has $2.88 billion in total assets spread ..... companies with an expense ratio of 0.48%. The top three holdings in IBB include: Regeneron Complete Story »

  5. Leveraged MLP and BDC ETFS.. MLPL and BDCL

    Commentary

    Sun, 14 Apr 2013

    yield is about 10.71% and pays quaterly. http://www. ibb .ubs.com/mc/etracs_US/mlp/alerian-long.shtml ..... yield is about 18.71% and pays quaterly. http://www. ibb .ubs.com/mc/etracs_US/bdc/wellsfargo-long.shtml

  6. Under The Hood: An Unheralded Biotech ETF

    Headlines

    Thu, 11 Apr 2013

    Vectors Biotech ETF ( BBH ) was leading the way with a year-to-date gain of over 21 percent. The iShares Nasdaq Biotechnology Index Fund ( IBB ), the largest biotech ETF by assets, has not been a slouch with a gain of 20.5 percent while

  7. Healthcare and biotech ETFs continue to churn higher again today, hitting new 52-week highs across the board: Health Care SPDR ([[XLV]] +1%), Vanguard Health Care ETF ([[VHT]] +0.9%), iShares Dow ...

    Headlines

    Thu, 11 Apr 2013

    highs across the board: Health Care SPDR ( XLV +1% ), Vanguard Health Care ETF ( VHT +0.9% ), iShares Dow Jones US Healthcare ( IYH +0.9% ),. Biotech ETF iShares NASDAQ Biotechnology Index ( IBB +1.3% ). Post your comment!

  8. New Battleground Emerges For Dendreon Bulls And Bears

    Headlines

    Mon, 8 Apr 2013

    By Brian L. Wilson : The fierce and unending battle between Dendreon (NASDAQ: DNDN ) bulls and bears has entered new territory: TV advertising. In a rather unconventional and unusual move, Dendreon management has been purchasing airtime for its Provenge commercial (which can be viewed here ). From

  9. Is There No End To The Biotech Bull Market?

    Headlines

    Thu, 4 Apr 2013

    Q2 2013- At All Time Highs The BTK and ETFs such as the IBB ( IBB ) and XBI ( XBI ) hit all time highs on April 2. Of course ..... points ago on the NASDAQ . Since 2012, the biotech ETF IBB has decoupled from NASDAQ and has outperformed it by 80

  10. How To Assess Real-World Portfolio Diversification

    Headlines

    Mon, 1 Apr 2013

    By John Dowdee : One of the central tenets of asset allocation is to select a diversified portfolio. The idea is intuitive; you do not keep all your eggs in one basket. Everyone talks about being diversified but there is little discussion on how you measure the degree of diversification. ...

« Prev12345Next »
Content Partners